Sun Pharma to buy US-based oncology firm with new skin cancer treatment product for $355 million

This is also Sun Pharma's second acquisition in less than three months and comes as the company looks to size up its specialty therapy portfolio.

Published on: Mar 10, 2025, 17:42:53 IST

By HT News Desk | Edited by Abhyjith K. Ashokan

Prefer HTon Google

Share via

Copy link

Sun Pharmaceutical Industries Ltd is buying US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for $355 million.

A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India, November 14, 2017. (Shailesh Andrade/Reuters)

This is also Sun Pharma's second acquisition in less than three months and comes as the company which is India’s largest drugmaker, looks to size up its specialty therapy portfolio.

Also Read: How layoffs are forcing older American professionals to take up blue-collar jobs

This comes at a time when Checkpoint has received approval from the US Food and Drug Administration (FDA) for UNLOXCYT, which can be used for treating adults with metastatic cutaneous squamous cell carcinoma (cSCC), the second-most common type of skin cancer in the US.

There are around 1.8 million cases of cSCC in the US annually, with about 40,000 cases turning severe, and 15,000 deaths ensuing, the firm had said in its exchange filing.

“Patients with cSCC may soon have access to an important, new treatment option,” said Dilip Shanghvi, Sun Pharma’s chairman said in the statement. “The acquisition further bolsters our innovative portfolio in onco-derm therapy.”

Also Read: Trump's tariffs on India may be good news, says ex-RBI deputy governor: Report

Meanwhile, James Oliviero, President and Chief Executive Officer of Checkpoint said: “I believe this transaction will provide accelerated access to UNLOXCYT in the United States, Europe and other markets worldwide.”

Sun Pharma will buy outstanding shares of the Waltham, Massachusetts-based Checkpoint for $4.10 each upfront, exercising a non-transferable contingent value of up to $0.70 per share in cash based on certain conditions, according to its exchange filing.

The payment of $4.10 per share is 66% above Checkpoint’s closing price on Friday, Sun Pharma had said.

The transaction is expected to be completed by June 2025, it added.

Also Read: Ola Electric stores see raids, seizures for allegedly not having trade certificates: Report

The US, which is the world’s largest market for pharmaceuticals, contributed about a third to Sun Pharma’s revenue in the financial year 2023-24.

ABOUT THE AUTHOR
HT News Desk
Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.